Beximco Pharmaceuticals Limited Job Circular 2021 has been published by the authority. Most of the people are unemployed in our country. It’s a big opportunity for all people. Because maximum people want to like a good job. This job is very necessary for them. It’s a great honor job. It’s a dream job for the people of our country. In this case, this job circular is too much important for the people.
As per the Beximco Pharmaceuticals Limited Job Circular 2021.
Beximco wants to hire a medical promotion executive. If you are interested in a pharmaceutical or in need of a job, you can try this job. This pots is a good post and will get a good amount of salary for you. This job needs a highly educated person who can manage this post.
Beximco started its operations in 1980 but was founded in 1976. It has a license to manufacturing products from the Upjohn Inc. of the United States and Bayer AG of Germany. Beximco produces over 500 products for fighting diseases like AIDS, Cancer, Diabetic, Asthma, and hypertension in both the national and international markets. Beximco was the first company that could sell its products to the US market.
Beximco Pharmaceuticals Limited Job Circular 2021 Apply System.
We provide many forms of academic programs like examination type form up, routine, notice admission date, examination result, and Job examination question resolution on our website. We have a tendency to try to publish government, Non-government, Banks, personal corporations, NGO jobs circulars. And that we tend to serve all Bangladeshi jobs and Admission take a look at examinations queries and it’s the answer.
Summary of Original Beximco Pharmaceuticals Limited Job Circular 2021.
Organization Name: Beximco Pharmaceuticals Limited
Posted on: August 11, 2021
Post name: Medical Promotion Executive
Job Nature: Full-Time
Vacancy: See Original Circular
Salary: See Original Circular
Educational Qualifications: Graduate Degree (Science up to SSC Level)
Job Location: See Original Circular
Official Website: Click Here
Application Deadline: 10 Oct 2021